Syngene (CMP: Rs 875; Market cap: Rs 35,216 crore; Rating: Overweight), the leading CRAMS (contract research and manufacturing services) player, posted a sequential growth in its Q2FY25 results.

Ashwin Ramaswami, a young Democrat from Johns Creek, is challenging the incumbent state senator, who was indicted alongside former President Trump for alleged interference in Georgia's 2020 election.

This move will significantly enhance the company's ability to advance the use of proteomics as a vital tool for the pharmaceutical and biotech industries. Building on recent strategic initiatives ...

However, the biotech has what it takes to be successful in the challenging gene-editing niche. This company might be worth far more than many realize. If I had to buy one share of any biotech with ...

US privately-held drug developer NImmune Biopharma has acquired development and commercialization rights for omilancor in Asia from Sino-American biotech LianBio. The covered markets include China, ...

AMA membership offers unique access to savings and resources tailored to enrich the personal and professional lives of physicians, residents and medical students. “Value-based care is really a ...

Maryland is a big player in the biotech and pharmaceutical industries ... This not only helps improve medical science but also gives hope to patients looking for answers when other treatments haven’t ...

If you're looking for a show-stopping appliance for your kitchen, take a look at the best American fridge freezers from our independent testing and read our expert buying advice. American fridge ...

In the biotech sector, foresight is key to avoiding supply chain disruption. Here's how to spot and mitigate potential bottlenecks: - Monitor inventory levels closely to anticipate and address ...

This website uses cookies to improve your experience. By continuing to use this website you are accepting our cookie policy. Some cookies are necessary to make the website work properly, for example ...